BioMark Diagnostics, Inc.: BioMark Selected by the Medical Alley and Investissement Quebec to Join the Us Go-To-Market Accelerator
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2022) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") an oncology-focused company with advanced near-to-market
Source: finanznachrichten.de